Accumulation of Pro-Cancer Cytokines in the Plasma Fraction of Stored Packed Red Cells

Journal of Gastrointestinal Surgery

Volumn 16, Issue 3, 2012, Pages 460-468

  Benson, Douglas D ^a,b   Beck, Adam W ^c   Burdine, Marie S ^c   Brekken, Rolf ^c   Silliman, Christopher C ^b,d   Barnett Jr , Carlton C ^a,b,d  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Bonfils Blood Center   (United States)

Author keywords

Cancer; Cytokines; Storage lesion; Transfusion

Indexed keywords

CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ANIMAL; ARTICLE; BLOOD STORAGE; CHEMISTRY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; MOUSE; PANCREAS TUMOR; PATHOLOGY; PLASMA; THROMBOCYTE; TUMOR CELL CULTURE;

ADENOCARCINOMA; ANIMALS; BLOOD PLATELETS; BLOOD PRESERVATION; CHEMOKINE CCL2; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PLASMA; PLATELET-DERIVED GROWTH FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856763681     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1798-x     Document Type: Article

References (37)

1. Yeh JJ, Gonen M, Tomlinson JS, Indrees K, Brennan MF, Fong Y. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumor of the pancreas. Br J Surg. 2007; 94: 466-472.
2. Park SJ, Kim SW, Jang JY, Lee KU, Park YH. Intraoperative transfusions: Is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy? World J Surg. 2002; 26: 487-492.
3. Blumberg N, Heal J, Chuang C, Murphy P, Agarwal M. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg. 1988; 207: 410-415.
4. Marsh J, Donnan PT, Hamer-Hodges DW. Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg. 1990; 77: 623-626.
5. Wobbes T, Joosen KH, Kuypers HH, Beerthuizen GI, Theeuwes GM. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma. Dis Col Rect. 1989; 32: 743-748.
6. Blajchman MA. The clinical benefits of leukoreduction of blood products. J Trauma. 2006; 60: S83-S90.
7. Benson D, Barnett CC Jr. Perioperative blood transfusions promote pancreas cancer progression. J Surg Res. 2011; 166: 275-279.
8. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev. 2007; 21: 327-348.
9. Barnett CC Jr, Beck AW, Holloway SE, Kehler M, Schluterman MK, Brekken RA, Fleming JB, Silliman CC. Intravenous delivery of the plasma fraction of stored packed red cells promotes pancreatic cancer growth in immunocompetent mice. Cancer. 2010; 116: 3862-3874.
10. Benson DD, Kelher MR, Meng X, Fullerton DA, Lee JH, Silliman CC, Barnett CC Jr. Gender-specific transfusion affects tumor-associated neutrophil: macrophage rations in murine pancreatic adenocarcinoma. J Gastrointest Surg. 2010; 14: 1560-1565.
11. Moore PK, Benson D, Kelher M, Moore EE, Fragoso M, Silliman CC, Barnett CC Jr. The plasma fraction of stored erythrocytes augments pancreas cancer metastasis in male versus female mice. J Surg Res. 2010; 164: 23-27.
12. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005; 105: 2266-2273.
13. Moore FA, Moore EE, Sauaia A. Blood transfusion: An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997; 132: 620-625.
14. Sillman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood. 2003; 101: 454-462.
15. Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ, Sillman CC. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes cytotoxicity: Abrogation by poststorage washing but not prestorage leukoreduction. J Trauma. 2001; 50: 426-432.
16. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998; 101: 1458-1467.
17. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994; 124: 684-694.
18. Offner PJ, Moore EE, Biffl WL, Johnson JL, Sillman CC. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg. 2002; 137: 711-717.
19. Romano G, Mastroianni C, Bancone C, Della Corte A, Galdieri N, Nappi G, De Santo LS. Leukoreduction program for red cell transfusions in cardiac surgery: association with reduced acute kidney injury and in-hospital mortality. J Thorac Cardiovasc Surg. 2010; 140: 188-195.
20. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994; 84: 1703-1721.
21. Vamvakas EC, Blajchman MA. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogenic blood transfusion. Transfus Med Rev. 2000; 14: 23-33.
22. Bilgin YM, Brand A. Transfusion-related immunomodulation: a second hit in an inflammatory cascade? Vox Sang. 2008; 95: 261-271.
23. Houbiers JG, Brand A, van de Watering LM, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE. Randomized control trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994; 344: 573-578.
24. van de Watering LM, Brand A, Houbiers JG, Klein-Kranenberg WM, Hermans J, van de Velde C, Cancer Recurrance and Blood transfusion study group. Perioperative blood transfusions, with or without allogenic leukocytes, relate to survival, not to cancer recurrence. Br J Surg. 2001; 88: 261-266.
25. Technical Manual. American Association of Blood Banks, Bethesda. 2003.
26. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-867.
27. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4: 71-78.
28. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumor progression: implications for new anticancer therapies. J Pathol. 2002; 196: 254-265.
29. Nozawa H, Chui C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA. 2006; 103: 12493-12498.
30. Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M, Wigler N, Keydar I, Ben-Baruch A. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 2002; 62: 1093-1102.
31. Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res. 2001; 7: 285-289.
32. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Trejo-Leider L, Leibovich-Rivkin T, Weitzenfield P, Meshel T, Shabtai E, Gutman M, Ben-Baruch A. Inflammatory mediators in breast cancer: Coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer. 2011; 11: 130 doi: 10. 1186/1471-2407-11-130.
33. ShimoyamaS, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res. 1996; 56: 2703-2706.
34. Fang S, Repo H, Joensuu H, Orpana A, Salven P. High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma. Eur J Cancer. 2011; doi: 10. 1016/j. ejca. 2011. 02. 018.
35. Shi X, Friess H, Kleef J, Ozawa F, Buchler MW. Pancreatic cancer: factors regulating tumor development, maintenance, and metastasis. Pancreatology. 2001; 1: 517-524.
36. Grandis JR, Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther. 2004; 102: 37-46.
37. Cao R, Bjorndahl MA, Religa P, Clasper S, Garvin S, Galter D, Meister B, Ikomi F, Tritsaris K, Dissing S, Ohhashi T, Jackson DG, Cao Y. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 2004; 6: 333-345.